{"brief_title": "Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy", "brief_summary": "The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is safe, tolerable and effective in treating painful HIV-associated neuropathy.", "condition": "Pain", "intervention_type": "Drug", "intervention_name": "Capsaicin Dermal Patch", "criteria": "Key Eligibility Criteria: - Must have had HIV-associated neuropathy for at least 2 months, with moderate to severe pain in both feet. - Must not have significant pain in feet due to other causes (for example, arthritis). - Must have intact skin at the treatment area. - Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (12 weeks). - Must not use topical pain medications for HIV-associated neuropathy. - Must be able to comply with study requirements such as completing daily pain diary and attending study visits. - Must be at least 18 years old, not pregnant, and be able to take care of self independently, with only occasional assistance if needed. - No significant medical problems of the heart, kidneys, liver or lungs, or cancer. - No history or current problem with substance abuse.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00085761.xml"}